Alessandro d’Ambrosio

Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study

Objective: The objective of this paper is to identify clinical or magnetic resonance imaging (MRI) predictors of long-term clinical progression in a large cohort of multiple sclerosis (MS) patients. Methods: A total of 241 relapsing–remitting (RR) MS patients were included in a nine-year follow-up (FU) study. The reference MRIs were acquired at baseline (BL) as part of a multicenter, cross-sectional, clinical-MRI study. Volumetric MRI metrics were measured by a fully automated, operator-independent, multi-parametric segmentation method. Clinical progression was evaluated as defined by: conversion from RR to secondary progressive (SP) disease course; progression of Expanded Disability Status Scale (EDSS); achievement and time to reach EDSS 4. Results: We concluded that conversion from RR to SP (OR 0.79; CI 0.7–0.9), progression of EDSS (OR 0.85; CI 0.77–0.93), achievement of EDSS 4 (OR 0.8; CI 0.7–0.9), and time to reach EDSS 4 (HR 0.88; CI 0.82–0.94) were all predicted by BL gray matter (GM) volume and, except for progression of EDSS, by BL EDSS (respectively: (OR 2.88; CI 1.9–4.36), (OR 2.7; CI 1.7–4.2), (HR 3.86; CI 1.94–7.70)). Conclusions: BL GM volume and EDSS are the best long-term predictors of disease progression in RRMS patients with a relatively long and mild disease.

Lesion Load May Predict Long-Term Cognitive Dysfunction in Multiple Sclerosis Patients

Background Magnetic Resonance Imaging (MRI) techniques provided evidences into the understanding of cognitive impairment (CIm) in Multiple Sclerosis (MS). Objectives To investigate the role of white matter (WM) and gray matter (GM) in predicting long-term CIm in a cohort of MS patients. Methods 303 out of 597 patients participating in a previous multicenter clinical-MRI study were enrolled (49.4% were lost at follow-up). The following MRI parameters, expressed as fraction (f) of intracranial volume, were evaluated: cerebrospinal fluid (CSF-f), WM-f, GM-f and abnormal WM (AWM-f), a measure of lesion load. Nine years later, cognitive status was assessed in 241 patients using the Symbol Digit Modalities Test (SDMT), the Semantically Related Word List Test (SRWL), the Modified Card Sorting Test (MCST), and the Paced Auditory Serial Addition Test (PASAT). In particular, being SRWL a memory test, both immediate recall and delayed recall were evaluated. MCST scoring was calculated based on the number of categories, number of perseverative and non-perseverative errors. Results AWM-f was predictive of an impaired performance 9 years ahead in SDMT (OR 1.49, CI 1.12–1.97 p = 0.006), PASAT (OR 1.43, CI 1.14–1.80 p = 0.002), SRWL-immediate recall (OR 1.72 CI 1.35–2.20 p<0.001), SRWL-delayed recall (OR 1.61 CI 1.28–2.03 p<0.001), MCST-category (OR 1.52, CI 1.2–1.9 p<0.001), MCST-perseverative error(OR 1.51 CI 1.2–1.9 p = 0.001), MCST-non perseverative error (OR 1.26 CI 1.02–1.55 p = 0.032). Conclusion In our large MS cohort, focal WM damage appeared to be the most relevant predictor of the long-term cognitive outcome.

Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory.

Background Depression occurs in about 50% of patients with multiple sclerosis. The aims of this study was to investigate the prevalence of depressive symptoms in a multicenter MS population using the Beck Depression Inventory II (BDI II) and to identify possible correlations between the BDI II score and demographic and clinical variables. Methods Data were collected in a multi-center, cross-sectional study over a period of six months in six MS centers in Italy using BDI II. Results 1,011 MS patients participated in the study. 676 subjects were female, with a mean age of 34 years (SD 10.8), mean EDSS of 3.3 (0–8.5) and mean disease duration of 10.3 years (range 1–50 years). 668 (%) subjects scored lower than 14 on the BDI II and 343 (33.9%) scored greater than 14 (14 cut-off score). For patients with BDI>14 multivariate analysis showed a significant difference between EDSS and disease course. BDI II scores for subjects with secondary progressive (SP) MS were significantly different from primary progressive (PP) patients (p < 0.001) but similar to relapsing-remitting (RR) patients. Considering subjects with moderate to severe depressive symptoms (BDI II score from 20–63), in relation to disease course, 11.7% (83/710) had RR MS, 40.7% (96/236) SP and 13.6% (6/44) PP. Conclusions Using the BDI II, 30% of the current sample had depressive symptoms. BDI II score correlates with disability and disease course, particularly in subjects with SP MS. The BDI II scale can be a useful tool in clinical practice to screen depressive symptoms in people with MS.

Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization

Objectives: To investigate resting-state functional connectivity (RS-FC) of the default-mode network (DMN) and of sensorimotor network (SMN) network in relapsing remitting (RR) multiple sclerosis (MS) patients with fatigue (F) and without fatigue(NF). Methods: In all, 59 RRMS patients and 29 healthy controls (HC) underwent magnetic resonance imaging (MRI) protocol including resting-state fMRI (RS-fMRI). Functional connectivity of the DMN and SMN was evaluated by independent component analysis (ICA). A linear regression analysis was performed to explore whether fatigue was mainly driven by changes observed in the DMN or in the SMN. Regional gray matter atrophy was assessed by voxel-based morphometry (VBM). Results: Compared to HC, F-MS patients showed a stronger RS-FC in the posterior cingulate cortex (PCC) and a reduced RS-FC in the anterior cingulated cortex (ACC) of the DMN. F-MS patients, compared to NF-MS patients, revealed (1) an increased RS-FC in the PCC and a reduced RS-FC in the ACC of the DMN and (2) an increased RS-FC in the primary motor cortex and in the supplementary motor cortex of the SMN. The regression analysis suggested that fatigue is mainly driven by RS-FC changes of the DMN. Conclusions: Fatigue in RRMS is mainly associated to a functional rearrangement of non-motor RS networks.

La terapia della sclerosi multipla

Allo stato attuale non esiste alcuna terapia in grado di guarire la sclerosi multipla (SM), ma le terapie a nostra disposizione permettono, a seconda della fase della malattia e del suo decorso, di trattare efficacemente l’episodio acuto, ridurre la frequenza delle ricadute e, parzialmente, la disabilita e di migliorare alcuni sintomi. Globalmente, pertanto, siamo in grado di modificare il decorso della malattia.

A simple measure of cognitive reserve is relevant for cognitive performance in MS patients

Cognitive reserve (CR) contributes to preserve cognition despite brain damage. This theory has been applied to multiple sclerosis (MS) to explain the partial relationship between cognition and MRI markers of brain pathology. Our aim was to determine the relationship between two measures of CR and cognition in MS. One hundred and forty-seven MS patients were enrolled. Cognition was assessed using the Rao’s Brief Repeatable Battery and the Stroop Test. CR was measured as the vocabulary subtest of the WAIS-R score (VOC) and the number of years of formal education (EDU). Regression analysis included raw score data on each neuropsychological (NP) test as dependent variables and demographic/clinical parameters, VOC, and EDU as independent predictors. A binary logistic regression analysis including clinical/CR parameters as covariates and absence/presence of cognitive deficits as dependent variables was performed too. VOC, but not EDU, was strongly correlated with performances at all ten NP tests. EDU was correlated with executive performances. The binary logistic regression showed that only the Expanded Disability Status Scale (EDSS) and VOC were independently correlated with the presence/absence of CD. The lower the VOC and/or the higher the EDSS, the higher the frequency of CD. In conclusion, our study supports the relevance of CR in subtending cognitive performances and the presence of CD in MS patients.

Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures

Cognitive reserve (CR) is a construct that originates from the observation of poor correspondence between brain damage and clinical symptoms. The aim of the study was to investigate the association between cognitive reserve (CR), brain reserve (BR) and cognitive functions and to evaluate whether CR might attenuate/moderate the negative impact of brain atrophy and lesion load on cognitive functions in multiple sclerosis (MS). To achieve these aims, ninety-eight relapsing-remitting MS patients underwent the brief repeatable battery of neuropsychological tests and Stroop test (ST). CR was assessed by vocabulary-based estimate of lifetime intellectual enrichment. All patients underwent a 3T MRI to assess T2-lesion load and atrophy measures, including normalized gray matter and white matter (nWMV) volumes. The BR was evaluated by maximal lifetime brain volume expressed by intracranial volume (ICV). Hierarchical regressions were used to investigate whether higher BR and/or CR is related to better cognitive performances after controlling for potentially confounding factors. The ICV was not associated with any cognitive tests. Intellectual enrichment was positively associated with performance on tests assessing memory, attention and information processing speed, verbal fluency and inhibitory control. Significant relationship between nWMV and ST was moderated by intellectual enrichment. In conclusion, the findings suggested that CR seems to mitigate cognitive dysfunction in MS patients and can reduce the negative impact of brain atrophy on inhibitory control, relevant for integrity of instrumental activities of daily living.

Therapy of Multiple Sclerosis

Currently there are no therapies able to heal Multiple Sclerosis (MS). However, depending on the stage and course of the disease, there are treatments available that can efficiently treat relapses, reduce relapse rate and, partially, disability progression, and improve some symptoms. This means that we are able to change the overall course of the disease.

Extra-motor involvement in ALS patients: a cortical thickness 3T MRI study

The abstracts have been reviewed by: F. Antonaci, Z. Argov, I. Arnulf, A. Arzimanoglou, T. Back, O. Bajenaru, E. Bartels, P.D. Berlit, K. Bhatia, P. Boon, T. Brandt, B. Brochet, M.J. Brodie, A. Bronstein, H. Cock, G. Comi, J. de Keyser, M. de Visser, L. Deecke, R. Dengler, S. Di Donato, H.C. Diener, M. Dieterich, V. Dietz, M. Donaghy, M. Eraksoy, T. Ettlin, F. Fazekas, L. Ferini-Strambi, J. Ferro, M. Filippi, D. Galimberti, A. Grau, W. Grisold, O. Hardiman, H.P. Hartung, W. Heide, C. Helmchen, D.M. Hermann, G. Ickenstein, L. Kappos, R. Khatami, B. Kieseier, T. Klopstock, C. Krarup, G. Lammers, G. Lauria, A. Luft, P. Lyrer, Z. Martinovic, G. Mayer, S.I. Mellgren, G. Meola, R. Milo, I. Milonas, C. Möller, X. Montalban, G. Moonen, M. Mumenthaler, N. Nardocci, O. Nascimento, E. Nobile-Orazio, W.H. Oertel, M. Onofrj, D. Pareyson, Y. Parman, H.W. Pfister, D. Pohl, P. Portegies, J. Rees, H. Reichmann, P.F. Reyes, A. Rossetti, M. Rousseaux, E. Ruzicka, G. Said, J. Santamaria, E. Scarpini, N. Schaeren-Wiemers, B. Schalke, P. Schestatsky, E. Schmutzhard, J. Schoenen, M. Seeck, A. Sena, S. Sergay, V. Silani, M. Sinnreich, A. Siva, R. Soffietti, C. Sommer, A. Steck, G. Stoll, D. Straumann, E. Tolosa, A. Toscano, K.V. Toyka, H. Tumani, J. Valls-Solé, J. van Gijn, P. Vermersch, M.J. Vidailhet, R.D. Voltz, J. Wokke We would like to thank the reviewers for their precious help and asistance.Children with “pure” receptive hearing impairment (RHI) and with specific language impairment (SLI) are not supposed to have additional developmental disabilities. However, mental health problems (MHP) may be associated with communicative disorders, and should be detected. Also motor coordination disorder (DCD) has an overlap of 50% with language developmental disorders. Screening and early detection of mental health and motor problems might have considerable health benefits for children with SLI. Aim of this study was to assess MHP and DCD in pure RHI and SLI. Methods: In a sample of 104 children (mean age 6.6 (SD 0.9) years; boys 71%) with well established SLI and of 51 RHI children (5-8 years old), we applied the parental strengths and difficulties questionnaire (SDQ) to detect mental health problems and DCD-criteria. DCD was defined as not only severe difficulties on the Movement-ABC-test (total score P5) and 5 neurological disorders (M-ABC